Free Trial

Oncolytics Biotech (ONCY) Institutional Ownership

Oncolytics Biotech logo
$0.36 -0.01 (-3.23%)
As of 11:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Oncolytics Biotech (NASDAQ:ONCY)

Current
Institutional Ownership
Percentage
6.82%
Number of
Institutional Buyers
(last 12 months)
16
Total
Institutional Inflows
(last 12 months)
$2.15M
Number of
Institutional Sellers
(last 12 months)
2
Total
Institutional Outflows
(last 12 months)
$87.93K
Get ONCY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oncolytics Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ONCY Institutional Buying and Selling by Quarter

Oncolytics Biotech Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/6/2026 Fifth Third Bancorp85,526$57K0.0%+87.9%0.065%
10/28/2026 International Assets Investment Management LLC462,008$310K0.0%+129.6%0.352%
9/8/2026Connective Capital Management LLC185,712$176K0.1%N/A0.146%
8/20/2026Susquehanna International Group LLP134,129$127K0.0%+224.6%0.105%
8/15/2026Vantage Point Financial LLC29,744$28K0.0%N/A0.025%
5/14/2026Renaissance Technologies LLC715,838$608K0.0%N/A0.616%
4/27/2026PFG Investments LLC52,900$45K0.0%+131.0%0.046%
2/23/2026Virtu Financial LLC77,883$68K0.0%N/A0.073%
2/19/2026Connective Capital Management LLC150,340$131K0.1%N/A0.142%
2/18/2026XTX Topco Ltd78,661$69K0.0%N/A0.074%
2/17/2026 Blair William & Co. IL31,467$28K0.0%N/A0.030%
2/13/2026Security National Bank of Sioux City Iowa IA33,255$29K0.0%N/A0.031%
2/13/2026Marshall Wace LLP262,170$228K0.0%-19.1%0.247%
2/12/2026Tocqueville Asset Management L.P.72,000$63K0.0%N/A0.068%
2/12/2026CIBC Private Wealth Group LLC50,000$44K0.0%N/A0.047%
2/10/2026Goldman Sachs Group Inc.169,899$148K0.0%-18.6%0.160%
2/4/2026 Ground Swell Capital LLC34,398$30K0.1%N/A0.032%
11/17/2025Scientech Research LLC18,204$25K0.0%N/A0.018%
11/17/2025Citadel Advisors LLC382,051$535K0.0%N/A0.381%
8/12/2025Seeds Investor LLC223,767$173K0.0%+17.8%0.230%
2/12/2025Geode Capital Management LLC66,939$61K0.0%+59.6%0.084%
2/12/2025National Bank of Canada FI64,479$60K0.0%+199.6%0.081%
2/11/2025Virtu Financial LLC98,452$90K0.0%N/A0.123%
1/24/2025Vantage Point Financial LLC29,744$27K0.0%N/A0.037%
1/8/2025International Assets Investment Management LLC200,400$186K0.0%+15.0%0.259%
10/22/2024International Assets Investment Management LLC174,331$152K0.0%-12.1%0.228%
5/20/2024Virtu Financial LLC51,889$55K0.0%N/A0.068%
1/24/2024International Assets Investment Management LLC269,699$364K0.0%+33.9%0.362%
1/12/2024Advisor Resource Council100,000$135K0.0%N/A0.134%
1/11/2024Ausdal Financial Partners Inc.30,000$40K0.0%+50.0%0.041%
11/8/2023Ausdal Financial Partners Inc.20,000$44K0.0%N/A0.027%
10/13/2023Brave Asset Management Inc.25,000$55K0.0%+150.0%0.035%
10/10/2023International Assets Investment Management LLC201,453$449K0.0%+3.3%0.278%
10/4/2023International Assets Investment Management LLC201,453$449K0.0%+3.3%0.278%
8/23/2023Headinvest LLC11,534$30K0.0%N/A0.016%
8/2/2023Bank of Montreal Can32,380$85K0.0%N/A0.049%
7/24/2023Brave Asset Management Inc.10,000$26K0.0%N/A0.015%
7/20/2023International Assets Investment Management LLC194,963$507K0.1%+3.4%0.297%
2/7/2023Lynwood Capital Management Inc.25,000$41K0.0%N/A0.041%
1/24/2023International Assets Investment Management LLC169,111$609K0.1%-6.9%0.276%
Why I'm selling my Snapback Indicator for just $7 (Ad)

For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.tc pixel

Get lifetime access to the Snapback Indicator for a one-time $7 payment today.
1/20/2023Newman Dignan & Sheerar Inc.18,915$31K0.0%+46.5%0.031%
8/11/2022Toronto Dominion Bank35,362$34K0.0%N/A0.061%


ONCY Institutional Ownership - Frequently Asked Questions

During the previous two years, 21 institutional investors and hedge funds held shares of Oncolytics Biotech. The most heavily invested institutionals were Renaissance Technologies LLC ($608K), Citadel Advisors LLC ($535K), International Assets Investment Management LLC ($310K), Marshall Wace LLP ($228K), Connective Capital Management LLC ($176K), Seeds Investor LLC ($173K), and Goldman Sachs Group Inc. ($148K).Learn more on Oncolytics Biotech's institutional investors.

6.82% of Oncolytics Biotech's stock is owned by institutional investors. Learn more on ONCY's institutional investor holdings.

Of the 19 institutional investors that purchased Oncolytics Biotech's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($715.84K), Citadel Advisors LLC ($382.05K), Connective Capital Management LLC ($336.05K), International Assets Investment Management LLC ($286.82K), Virtu Financial LLC ($176.34K), Susquehanna International Group LLP ($92.81K), and XTX Topco Ltd ($78.66K).

Institutional investors have bought a total of 2,283,107 shares in the last 24 months. This purchase volume represents approximately $2.15M in transactions.

The following institutional investors have sold Oncolytics Biotech stock in the last 24 months: Marshall Wace LLP ($61.81K), and Goldman Sachs Group Inc. ($38.80K).

Institutional investors have sold a total of 100,611 shares in the last 24 months. This volume of shares sold represents approximately $87.93K in transactions.



Institutional ownership data for NASDAQ:ONCY is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 11/6/2026. New 13F filings are added each quarter as they're published.
From Our Partners